Metraipolis › archive › dc_e2dd5f0aa289
HBV reactivation during immunotherapy for hepatocellular carcinoma: risk factors and clinical management — Europe PMC PMID:41743730
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41743730
- DOI
- 10.3389/fimmu.2026.1765054
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T23:21:35.562Z
- SHA-256 of the archived text
53ad0807474238100a6231834bc0aac4d31ecc698a52f66822c43e8675179cf2- Stable URL of this page
https://metraipolis.com/documento/dc_e2dd5f0aa289
How to cite
HBV reactivation during immunotherapy for hepatocellular carcinoma: risk factors and clinical management — Europe PMC PMID:41743730 — Europe PMC (en), https://europepmc.org/article/MED/41743730 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e2dd5f0aa289 (Metraipolis archive dc_e2dd5f0aa289, sha256 53ad0807474238100a6231834bc0aac4d31ecc698a52f66822c43e8675179cf2)
BibTeX
@misc{dce2dd5f0aa289,
title = {HBV reactivation during immunotherapy for hepatocellular carcinoma: risk factors and clinical management — Europe PMC PMID:41743730},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41743730},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e2dd5f0aa289; sha256 53ad0807474238100a6231834bc0aac4d31ecc698a52f66822c43e8675179cf2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41743730. Agents can read the archived copy with the MCP tool read_document.